Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RIVFLOZA safely and effectively. See full prescribing information for RIVFLOZA.RIVFLOZA® (nedosiran) injection, for subcutaneous useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
RIVFLOZA is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥30 mL/min/1.73 m2 [see Clinical Pharmacology (12.3)], Clinical Studies (14.1)].
- generic_name
- nedosiran
- product_names
- nedosiran
- ndc
- 0169-5306, 0169-5306-10, 0169-5307, 0169-5307-08, 0169-5308, 0169-5308-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en